Ming-Tain Lai

Title: The Innovations of Ming-Tain Lai

Introduction

Ming-Tain Lai is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of chemistry, particularly in the synthesis of high enantioselective secondary alcohols. His innovative approaches have led to advancements in pharmaceutical compounds, showcasing his expertise and dedication to research.

Latest Patents

Ming-Tain Lai holds a patent for "Methods of making high enantioselective secondary alcohols." This patent describes a new process for synthesizing the compound OBI-3424 in both R-form and S-form products. The R-form compound OBI-3423 was synthesized with an overall yield of 48% from compound OBI-3424-5 by installing the labile phosphate motif at a later stage. The stereochemistry is established through a five-step chemo-enzyme combination synthesis, achieving 99% optical purity. Subsequently, the S-form compound OBI-3424 is prepared, improving the overall yield to 54% from compound OBI-3424-5, with excellent optical purity of 99% established through a four-step combination of chemo-enzyme synthesis.

Career Highlights

Ming-Tain Lai is associated with Obi Pharma Inc., where he continues to push the boundaries of chemical synthesis. His work has not only contributed to the scientific community but has also paved the way for potential therapeutic applications in medicine.

Collaborations

Ming-Tain Lai has collaborated with notable colleagues, including Cheng-Der Tony Yu and Yin-Cheng Hsieh. These partnerships have enhanced his research and contributed to the successful development of innovative processes in his field.

Conclusion

Ming-Tain Lai's contributions to the field of chemistry, particularly through his patent on high enantioselective secondary alcohols, highlight his role as a leading inventor. His work at Obi Pharma Inc. and collaborations with esteemed colleagues further emphasize his impact on pharmaceutical innovations.